Temperature-controlled healthcare logistics capacity is expanding with the addition of four new airfreight corridors connecting major pharmaceutical and healthcare hubs across Europe, North America, Asia-Pacific, and Latin America.
The expanded network strengthens the movement of vaccines, biologics, peptides, and other temperature-sensitive products through dedicated GDP-compliant transport routes designed to maintain product integrity and reduce temperature risks during transit. Enhanced handling processes and improved airfreight connectivity also enable more efficient, reliable, and sustainable healthcare supply chains.
The expansion reflects growing investment in resilient cold chain infrastructure, supporting faster global distribution of critical healthcare products while improving supply chain efficiency, reducing logistics costs, and advancing sustainable transportation.
#SupplyChain #ColdChain #HealthcareLogistics #AirCargo #Pharmaceuticals #Logistics #GlobalTrade #SupplyChainResilience
